Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sacubitril/valsartan versus valsartan after PCI for acute myocardial infarction
ChiCTR2000039437Phase 4Recruiting
- Sponsor
- Sir Run-Run Shaw Hospital
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of sacubitril + valsartan and valsartan in myocardial infarction (MI) (2 arms), sponsored by Sir Run-Run Shaw Hospital. Primary endpoints: Left ventricular ejection fraction, Left ventricular end-diastolic diameter and 4 more. Started Oct 2020; status: recruiting.
02
Drugs
sacubitril + valsartanvalsartan
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on ChiCTR2000039437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000039437.